GENE ONLINE|News &
Opinion
Blog

2018-03-06|

6 March, 2014: First time Scientist gene-editing Immune Cells Successful, open a new treatment possibility for AIDS

by GeneOnline
Share To

A research team from the Perelman School of Medicine, University of Pennsylvania, enrolled 12 patients in an uncontrolled study of a single dose of ZFN-modified autologous CD4 T cells. The patients had the chronic aviremic HIV infection while they were receiving highly active antiretroviral therapy. After the infusion of 10 billion autologous CD4 T cells, the blood level of HIV DNA decreased in most patients. This study was a milestone for gene-editing technology application on fatal disease treatment.

Reference
http://www.nejm.org/doi/full/10.1056/NEJMoa1300662

Image Source
https://en.wikipedia.org/wiki/HIV

©www.geneonline.com All rights reserved. Collaborate with us: service@geneonlineasia.com
Related Post
R&D
Study Finds High Viral Loads Fuel Higher HIV Recombination Rates
2024-01-12
GSK Boosts HIV Drug Business Forecasts as Apretude Sales Surge
2023-10-03
R&D
New White Blood Cell Subtype as HIV Reservoir Identified
2023-04-07
LATEST
Eli Lilly Breaks Records with $9B Total Investment in Indiana Weight-loss Drug Expansion
2024-05-27
New Regulatory Measures in China A First in the Fight Against Sedentary Behavior in Children
2024-05-24
Cure Genetics Announced Promising Safety and Efficacy Data of CAR-NKT Product CGC729 for RCC at ASGCT 2024
2024-05-23
AstraZeneca’s $1.5 Billion ADC Manufacturing Facility in Singapore
2024-05-23
Hims & Hers Health Inc. Tipping the Scales of the Weight Loss Market — and Wall Street is Loving it!
2024-05-22
GV Announces Cooperation with CICC
2024-05-22
Eli Lilly and Aktis Oncology Partner to Advance Novel Radiopharmaceuticals
2024-05-22
EVENT
Scroll to Top